Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/09/path-stock-slides-as-earnings-disappoint-and-wall-street-stays-cautious.jpg
https://stockstotrade-nuxt-staging.stockstotrade-com-inc.workers.dev/

PATH Stock Slides As Earnings Disappoint And Wall Street Stays Cautious

TIM BOHENUPDATED SEP. 9, 2026, 4:47 PM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

UiPath Inc. stocks have been trading down by -3.44 percent amid negative sentiment over automation demand and AI competition.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading PATH

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

  • Wall Street saw mixed fiscal Q2 results and only modest margin progress, keeping expectations for PATH in check.
  • BofA lifted its PATH price target from $13 to $15 but kept an Underperform rating, signaling ongoing skepticism on the growth story.
  • Shares of UiPath Inc. dropped roughly 11%–17% after the latest quarterly release, a clear sign of shaken confidence.
  • Insider selling by CEO Daniel Dines, about 1.4 million shares worth $22.5M, adds another layer for PATH traders to watch, even as he still holds 26.5 million Class A shares.

Candlestick Chart

Live Update At 16:47:04 EDT: On Wednesday, September 09, 2026 UiPath Inc. stock [NYSE: PATH] is trending down by -3.44%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

PATH has been on a rough ride. In late August, UiPath Inc. traded near $18–$18.50, closing at $18.67 on 2026/08/31. Since then, the stock has slid steadily, closing at $13.57 on 2026/09/09. That is a drawdown of roughly 27% in under two weeks, driven largely by a harsh earnings reaction.

On the latest reported quarter ending 2026/07/31, UiPath Inc. posted about $410.3M in revenue and $36.1M in net income, translating into a slim but positive profit. PATH is no longer a cash-burning story; it generated roughly $29.3M in free cash flow and holds about $608.9M in cash, with total cash and short-term investments of roughly $1.28B. Debt is minimal, with long-term debt around $69.4M and a low 0.04 debt-to-equity ratio.

More Breaking News

Valuation is still not trivial. PATH trades at around 25 times earnings and 4.7 times sales, with an 83% gross margin that shows strong pricing power, but also high expectations. For traders, that combo — high margin, mid-teens revenue growth, positive cash flow, and a sharp chart breakdown — sets the stage for volatile trading as sentiment resets.

Why Traders Are Watching PATH After The Post-Earnings Flush

The real story for PATH traders is the brutal reaction to earnings. UiPath Inc. released its latest quarterly numbers late Thursday, and the market did not like what it saw. The stock dropped roughly 11% in early trading and, across the day and follow‑through, various reports pegged the total slide around 16%–17%. That kind of air pocket tells you expectations were far above reality.

PATH is supposed to be an AI winner. Yet Bank of America’s move says a lot: the firm raised its price target from $13 to $15, but still labeled UiPath Inc. as Underperform. In plain English, BofA is saying, “Yes, margins are improving a bit, but we don’t buy the idea that AI will suddenly turbo‑charge ARR growth.” For active traders, that is a clear signal that big money remains cautious on PATH.

On the tape, PATH has gone from an $18 handle before earnings to the low‑$13s. The daily chart shows a waterfall from 2026/09/03 to 2026/09/09, while the intraday action around $13.50–$13.70 looks like tired consolidation, not aggressive dip‑buying. PATH keeps failing to reclaim $14 with strength; every push toward that level fades.

Then you have the insider angle. UiPath Inc. CEO Daniel Dines sold about 1.4 million shares, roughly $22.5M worth, while still keeping control of about 26.5 million Class A shares. Traders tend to read large insider sales after a weak quarter as another confidence check. It does not mean he is abandoning PATH — his remaining stake is huge — but it does make short‑term players more skittish.

For momentum and gap‑down traders, PATH is now a classic “broken expectations” story where bounces can be sharp but fragile.

Conclusion

PATH now sits in that dangerous zone where the story sounds great — AI, automation, huge gross margins — but the price action says trust has been damaged. UiPath Inc. is profitable on paper, with positive free cash flow, a strong balance sheet, and almost no debt. Yet traders are clearly questioning the growth runway and whether the AI buzz will really speed up ARR the way the bulls once hoped.

BofA’s call on PATH sums it up. A higher $15 target gives UiPath Inc. some credit for cost control and margin work, but the Underperform rating and doubts about AI‑driven acceleration cap enthusiasm. When Wall Street is that lukewarm and the chart is bleeding lower, reactive trading usually dominates. PATH becomes a battlefield between dip‑buyers anchoring to prior highs and short sellers leaning into the broken trend.

The key now is price action, not hype. PATH needs to prove it can hold support in the low‑$13s and then build a series of higher lows before any real trend shift. Until then, PATH is a textbook teaching example for traders. As Tim Sykes likes to remind students, “The market doesn’t care about your opinion, only about price and volume — learn to read both, or you’re just guessing.” That’s why having a clear trading plan and scanning the market ahead of time matters so much. As Tim Bohen, lead trainer with StocksToTrade says, “Preparation is half the trade. By the time the bell rings, my decisions are nearly made.”. For educational and research‑focused traders, UiPath Inc. is a live case study in exactly that.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders